P245 Evaluation of the relationship between fecal calprotectin concentrations and clinical and endoscopic outcome measures in a phase 2 study of tofacitinib, an oral janus kinase inhibitor, in active ulcerative colitis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.